Search Results
CR 518S Clinical Trial Budgeting 3.0 Credits
The overall cost of drug development has increasingly become a controversial subject with estimates varying from hundreds of million to over a billion dollars. One of the larger components contributing to this is the cost of clinical trials required for regulatory approval. Accuracy in the development of clinical trial budgets is crucial for both small and large pharmaceutical companies. The budget variance for clinical studies, from forecast to actual costs, averages about 10%. Overestimating the cost of clinical studies is equally problematic and results in wasted resources and a higher opportunity cost.
Repeat Status: Not repeatable for credit
